His primary areas of investigation include Immunology, Virology, Cytotoxic T cell, Immunity and CD8. In his study, which falls under the umbrella issue of Immunology, Peripheral blood mononuclear cell and Immunization is strongly linked to HIV vaccine. The various areas that M. Juliana McElrath examines in his Virology study include Epitope, Antibody, CTL* and AIDS Vaccines.
In Cytotoxic T cell, M. Juliana McElrath works on issues like Immunopathology, which are connected to Simian immunodeficiency virus. M. Juliana McElrath usually deals with Immunity and limits it to topics linked to Viremia and Immunodeficiency. His CD8 research includes themes of Flow cytometry and Viral load.
His primary scientific interests are in Immunology, Virology, Vaccination, HIV vaccine and Immune system. Immunology is frequently linked to Cytotoxic T cell in his study. M. Juliana McElrath interconnects Epitope, Antibody, Antigen and CTL* in the investigation of issues within Virology.
His work on Vaccine efficacy as part of general Vaccination research is often related to Placebo, thus linking different fields of science. M. Juliana McElrath has included themes like ELISPOT, Peripheral blood mononuclear cell, Clinical trial and AIDS Vaccines in his HIV vaccine study. His work carried out in the field of Virus brings together such families of science as Cellular immunity and Immunopathology.
Antibody, Vaccination, Immunology, HIV vaccine and Virology are his primary areas of study. His studies in Vaccination integrate themes in fields like Vector, Internal medicine and Reactogenicity, Immunogenicity. The study incorporates disciplines such as HVTN 505 and Peripheral blood mononuclear cell in addition to Immunology.
His HIV vaccine research includes elements of Regimen, Antibody-dependent cell-mediated cytotoxicity, Immune system, Antigen and Vaccine trial. As a part of the same scientific family, he mostly works in the field of Antigen, focusing on T cell and, on occasion, Cancer research. M. Juliana McElrath combines subjects such as Epitope, Monoclonal antibody and Severe acute respiratory syndrome coronavirus 2 with his study of Virology.
His scientific interests lie mostly in Antibody, Virology, Vaccination, 2019-20 coronavirus outbreak and Severe acute respiratory syndrome coronavirus 2. His Antibody study combines topics in areas such as HVTN 505, Virus, Receptor and Monocyte. His Virus research entails a greater understanding of Immunology.
His Virology study frequently links to related topics such as Epitope. His Epitope research incorporates elements of Mutation, Viremia, Immune system, Immunotherapy and Glycan. He has researched Vaccination in several fields, including Reactogenicity and Immunogenicity.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner.
The New England Journal of Medicine (2012)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.
Susan P Buchbinder;Devan V Mehrotra;Ann Duerr;Daniel W Fitzgerald.
The Lancet (2008)
Integrated analysis of multimodal single-cell data
Yuhan Hao;Stephanie Hao;Erica Andersen-Nissen;William M. Mauck.
MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data
Greg Finak;Andrew McDavid;Masanao Yajima;Jingyuan Deng.
Genome Biology (2015)
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
M Juliana McElrath;M Juliana McElrath;Stephen C De Rosa;Stephen C De Rosa;Zoe Moodie;Sheri Dubey.
The Lancet (2008)
Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.
L Musey;J Hughes;T Schacker;T Shea.
The New England Journal of Medicine (1997)
Setting the stage: host invasion by HIV.
Florian Hladik;M. Juliana McElrath;M. Juliana McElrath.
Nature Reviews Immunology (2008)
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
Scott M. Hammer;Magdalena E. Sobieszczyk;Holly Janes;Shelly T. Karuna.
The New England Journal of Medicine (2013)
Initial Events in Establishing Vaginal Entry and Infection by Human Immunodeficiency Virus Type-1
Florian Hladik;Florian Hladik;Polachai Sakchalathorn;Lamar Ballweber;Gretchen Lentz.
A Blueprint for HIV Vaccine Discovery
Dennis R. Burton;Rafi Ahmed;Rafi Ahmed;Dan H. Barouch;Dan H. Barouch;Dan H. Barouch;Salvatore T. Butera.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: